TY - JOUR T1 - Oncological Outcome and Prognostic Factors of Surgery for Soft Tissue Sarcoma After Neoadjuvant or Adjuvant Radiation Therapy: A Retrospective Analysis over 15 Years JF - Anticancer Research JO - Anticancer Res SP - 359 LP - 368 DO - 10.21873/anticanres.14784 VL - 41 IS - 1 AU - HEINRICH M.L. MUEHLHOFER AU - BENJAMIN SCHLOSSMACHER AU - ULRICH LENZE AU - FLORIAN LENZE AU - RAINER BURGKART AU - ALEXANDRA S. GERSING AU - JAN C. PEEKEN AU - STEPHANIE E. COMBS AU - RUEDIGER VON EISENHART-ROTHE AU - CAROLIN KNEBEL Y1 - 2021/01/01 UR - http://ar.iiarjournals.org/content/41/1/359.abstract N2 - Background/Aim: Surgical resection for soft tissue sarcomas (STSs) is the gold standard for a curative oncologic therapy in combination with neoadjuvant or adjuvant radiation therapy (NRT/ART). The aim of this study was to determine prognostic factors influencing the survival of patients with STS undergoing NRT or ART considering various parameters in a retrospective, single-centre analysis over 15 years. Patients and Methods: We included 119 patients (male 59) and the median follow-up period was 69 months (4-197). The patients received NRT (n=64) or ART (n=55). We recorded the histopathologic subtype of STS, tumour grade, localization, tumour margins, complications, survival, local recurrence, and metastases. Survival analysis was performed using the Kaplan–Meier method. Results: The overall survival rate was 68.9% at 5 years. The localization (epifascial/subfascial), resection margin and type of radiation therapy (NRT/ART) had no significant impact on survival. Tumour grade, tumour size, local recurrence and metastases were significantly correlated with patient survival (p<0.05). Local recurrence was significantly higher in patients with ART (p=0.044). Conclusion: Tumour grade and tumour size were independently associated with disease-specific survival, and patients with local recurrence and metastases had lower survival rates. ER -